Claire E. Owen
Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study
Owen, Claire E.; Goodman, Susan M.; Simon, Lee S.; Mackie, Sarah L.; Hill, Catherine L.; Yates, Max; Owen, Claire E; Muller, Sara; Graham, Karly; Neill, Lorna; Twohig, Helen; Boers, Maarten; Pujades Rodriguez, Mar; Goodman, Susan; Cheah, Jonathan; Dejaco, Christian; Mukhtyar, Chetan; Nielsen, Berit Dalsgaard; Robson, Joanna; Simon, Lee S; Shea, Beverley; Mackie, Sarah L; Hill, Catherine L
Authors
Susan M. Goodman
Lee S. Simon
Sarah L. Mackie
Catherine L. Hill
Max Yates
Claire E Owen
Sara Muller
Karly Graham
Lorna Neill
Helen Twohig
Maarten Boers
Mar Pujades Rodriguez
Susan Goodman
Jonathan Cheah
Christian Dejaco
Chetan Mukhtyar
Berit Dalsgaard Nielsen
Jo Robson Jo.Robson@uwe.ac.uk
Consultant Associate Professor in Rheumatology
Lee S Simon
Beverley Shea
Sarah L Mackie
Catherine L Hill
Abstract
OBJECTIVE: To survey participants with polymyalgia rheumatica (PMR) to evaluate the face validity, acceptability, and domain match of proposed candidate outcome measures. METHODS: A structured, online, anonymous survey was disseminated by patient support groups through their networks and online forums. The candidate outcome measures comprised (1) visual analog scale (VAS) and numerical rating score (NRS) to assess pain; (2) VAS, NRS, and duration to assess stiffness; (3) the modified Health Assessment Questionnaire and Health Assessment Questionnaire Disability Index to assess physical function; and (4) C-reactive protein and erythrocyte sedimentation rate to assess inflammation. Free-text answers were analyzed using descriptive thematic analysis to determine respondents' views of the candidate instruments. RESULTS: Seventy-eight people with PMR from 6 countries (UK, France, USA, Canada, Australia, and New Zealand) participated in the survey. Most respondents agreed candidate instruments were acceptable or "good to go." Free-text analysis identified 5 themes that participants considered inadequately covered by the proposed instruments. These related to (1) the variability, context, and location of pain; (2) the variability of stiffness; (3) fatigue; (4) disability; and (5) the correlation of inflammatory marker levels and severity of symptoms, sometimes reflecting disease activity and other times not. CONCLUSION: Participants reported additional aspects of their experience that are not covered by the proposed instruments, particularly for the experience of stiffness and effect of fatigue. New patient-reported outcome measures are required to increase the relevance of results from clinical trials to patients with PMR.
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 20, 2019 |
Online Publication Date | Feb 1, 2020 |
Publication Date | Sep 1, 2020 |
Deposit Date | May 15, 2020 |
Publicly Available Date | Feb 2, 2021 |
Journal | The Journal of Rheumatology |
Print ISSN | 0315-162X |
Electronic ISSN | 1499-2752 |
Publisher | Journal of Rheumatology |
Peer Reviewed | Peer Reviewed |
Volume | 47 |
Issue | 9 |
Pages | 1379-1384 |
DOI | https://doi.org/10.3899/jrheum.190575 |
Keywords | Immunology; Immunology and Allergy; Rheumatology |
Public URL | https://uwe-repository.worktribe.com/output/5975276 |
Files
Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study
(718 Kb)
PDF
Licence
http://www.rioxx.net/licenses/all-rights-reserved
Publisher Licence URL
http://www.rioxx.net/licenses/all-rights-reserved
Copyright Statement
This the accepted manuscript of an article accepted for publication in The Journal of Rheumatology.
You might also like
The OMERACT emerging leaders program: The good, the bad, and the future
(2019)
Journal Article
Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018
(2019)
Journal Article